through Celite, washed with THF (3 x 50 mL) and the organic filtrate was concentrated in vacuo and used in the next reaction without further purification. In a separate 250 mL round-bottomed flask equipped with a magnetic stir bar, dipeptide S1 (779 mg, 1.59 mmol) was dissolved in 50 mL of TFA and stirred at room temperature for 30 min. The solution was concentrated in vacuo and the solvents were removed by azeotropic distillation with toluene (3 x 50 mL).
To a third 250 mL round-bottomed flask equipped with a magnetic stir bar, the freshly hydrogenolyzed Boc-L-pHPG-L-Arg(Pbf)-COOH dipeptide was added in 30 mL of reagent grade DMF.
To this was solution added DIPEA (415 µL, 2.35 mmol) and the solution was cooled to 0 °C in an icebath. The freshly deprotected peptide S1 was dissolved in 20 mL of reagent grade DMF, DIPEA (415 µL, 2.35 mmol) was added and the solution was cooled to 0 °C in an ice-bath. After both solutions were sufficiently cooled, PyBOP (911 mg, 1.75 mmol) was added to the flask containing the carboxylate and after 1 min, freshly deblocked S1 was added dropwise over 2 min. The reaction mixture was stirred from 0 °C to room temperature over 3 h. The reaction mixture was diluted with 150 mL of EtOAc and washed with sat. aq. NH 4 Cl (2 x 75 mL), sat. aq. NaHCO 3 (2 x 75 mL) and brine
(1 x 75 mL). The organic layer was concentrated in vacuo and purified by silica gel chromatography using a gradient of 50: 50 EtOAc: Hex to 80: 20 EtOAc: Hex over 3 L to obtain the product as a white foam (0.95 g, 65% 
L-[p-(Hydroxy)phenyl]glycyl-L-arginyl-D-[p-(hydroxy)phenyl]glycyl-L-seryl-S-coenzyme A (1).
To a 50 mL round-bottomed flask equipped with a magnetic stir bar, S2 (400 mg, 0.39 mmol) was dissolved in 10 mL of reagent grade THF. To this solution was added a catalytic amount of Pd-OH/C and the tetrapeptide was hydrogenated under 1 atm. of H 2 for 12 h. The mixture was filtered through Celite, washed with THF (3 x 20 mL) and the organic filtrate was concentrated in vacuo and used in the next reaction without further purification.
To a 10 mL round-bottomed flask equipped with a magnetic stir bar, freshly hydrogenolyzed tetrapeptide S2 (40.0 mg, 0.044 mmol) was dissolved in 500 µL of THF and to this solution was 
II. Synthesis of L-pHPG-L-
To a 10 mL round-bottomed flask, protected peptide S2 (210 mg, 0.318 mmol) was dissolved in 4 mL of reagent grade THF. To this solution was added a catalytic amount of Pd-OH/C and the protected tetrapeptide was deblocked at 1 atm. of H 2 for 12 h. The mixture was filtered through Celite, washed with THF (3 x 10 mL) and the organic filtrate was concentrated in vacuo and used in the next reaction without further purification.
To a 10 mL round-bottomed flask equipped with a magnetic stir bar, freshly hydrogenolyzed 
III. Synthesis of D-pHPG-L-Ser-S-Coenzyme A (4)

D-[p-(hydroxy)phenyl]glycyl-L-seryl-S-coenzyme A (4).
To a 10 mL round-bottomed flask equipped with a magnetic stir bar, freshly hydrogenolyzed dipeptide S1 (25.0 mg, 0.057 mmol) was dissolved in 500 µL of THF and to this solution was added K 2 CO 3 (21.0 mg, 0.169 mmol). In a separate vial coenzyme A (66.0 mg, 0.086 mmol) was dissolved in 500 µL of HPLC grade water.
PyBOP (44.0 mg, 0.086 mmol) was added to the solution containing hydrogenolyzed S1 followed by the addition of the aqueous solution of coenzyme A. The reaction was stirred at room temperature for
HO
The reaction solution were purified by Prep Method A, collected on dry ice and lyophilized to dryness.
The desired freshly lyophilized product was dissolved in 5 mL of reagent grade TFA and stirred at room temperature for 15 min. The TFA was removed in vacuo and the residue was re-suspended in 2 mL of 70: 30 H 2 O: ACN supplemented with 0.1% TFA. The reaction mixture was purified by Prep Method A again, collected, frozen on dry ice and lyophilized to a white TFA salt (20.0 mg, 35% 
IV. Synthesis of L-pHPG-L-Arg-D-pHPG-dehydroalanyl-S-3'-dephospho Coenzyme A (6)
S3
N-tert-Butyloxycarbonyl-D-[p-(hydroxy)phenyl]glycine Benzyl Ester (S3).
To a 500 mL roundbottomed flask, equipped with a magnetic stir bar, Boc-D-pHPG (7.00g, 26.19 mmol) was dissolved in 50 mL of freshly distilled THF. To this solution was added TEA (4.38 mL, 31.43 mmol) and benzyl bromide (3.43 mL, 28.81 mmol). The solution was left to stir at room temperature overnight. The reaction solvent was removed in vacuo and 300 mL of EtOAc was added to the concentrate and the organic solution was washed with 2 x 100 mL of sat. NH 4 Cl (aq) and 1 x 100 mL sat. NaCl (aq). The organic layer was concentrated in vacuo and purified by silica gel chromatography with an isocratic mixture of 80: 20 Hex: EtOAc to afford the product as a white foam (4.99 g, 53% The reaction mixture was poured into a separatory funnel containing 300 mL of EtOAc and the organic mixture was washed 2 x 100 mL sat. NH 4 Cl (aq) and 1 x 100 mL sat. NaCl (aq). The organic layer was concentrated in vacuo and purified by silica gel chromatography with an isocratic mixture of 90: 10 Hex: EtOAc to afford the product as a white foam (6.32 g, 96%). 
S5
N-tert-Butyloxycarbonyl-D-[p-(tert-butyldimethylsilyl)phenyl]glycyl-L-serine Benzyl Ester (S5).
To a 25 mL round-bottomed flask, protected peptide S4 (3.21 g, 6.81 mmol) was dissolved in 10 mL of reagent grade THF. To this solution was added a catalytic amount of Pd-OH/C and the protected amino acid was deblocked at 1 atm. of H 2 for 12 h. The mixture was filtered through Celite, washed with THF (3 x 20 mL) and the organic filtrate was concentrated in vacuo and used in the next reaction without further purification. 
S6
N-tert-Butyloxycarbonyl-L-[p-(tert-butyldimethylsilyl)phenyl]glycyl-L-arginine(Pbf) Benzyl Ester (S6). To a 250 mL round-bottomed flask, equipped with a magnetic stir bar N-tert-
butyloxycarbonyl-L-[p-(hydroxy)phenyl]glycyl-L-argininel(Pbf) benzyl ester 1 (2.00 g, 2.62 mmol) was dissolved in 50 mL of anhydrous DMF. To this was added imidazole (0.53 g, 7.86 mmol) followed by the addition of t-BDMS-Cl (0.47 g, 3.14 mmol). The reaction was stirred at room temperature overnight under Ar. The reaction mixture was poured into a separatory funnel containing 300 mL of EtOAc and the organic mixture was washed 2 x 100 mL sat. NH 4 Cl (aq) and 1 x 100 mL sat. NaCl , 2H), 6.14 (br. s, 1H 
S7
N-tert-butyloxycarbonyl-L-[p-(tert-butyldimethylsilyl)phenyl]glycyl-L-arginyl(Pbf)-D-[p-(tert-
butyldimethylsilyl)phenyl]glycyl-L-serine Benzyl Ester (S7).
To a 250 mL round-bottomed flask equipped with a magnetic stir bar, the N-terminal dipeptide S6 (1.70 g, 1.93 mmol) was dissolved in 20 mL of reagent grade THF. To this solution was added a catalytic amount of Pd-OH/C and the protected dipeptide was hydrogenated under 1 atm. of H 2 for 12 h. The mixture was filtered through Celite, washed with THF (3 x 50 mL) and the organic filtrate was concentrated in vacuo and used without further purification. In a separate 250 mL round-bottomed flask equipped with a magnetic stir bar, the C-terminal dipeptide S5 (1.29 g, 2.32 mmol) was dissolved in 50 mL of TFA and stirred at room temperature for 30 min. The solution was concentrated in vacuo and residual solvent was removed by azeotropic distillation with toluene (3 x 50 mL).
To a 250 mL round-bottomed flask equipped with a magnetic stir bar, freshly hydrogenolyzed S6 was added in 30 mL of freshly distilled DCM. To this was solution added DIPEA (0.50 mL, 2.90 mmol) and the solution was cooled to 0 °C in an ice-bath.
Si was dissolved in 20 mL of freshly distilled DCM, DIPEA (0.50 mL, 2.90 mmol) was added and the solution was cooled to 0 °C in an ice-bath. After both dipeptide containing solutions were sufficiently cooled, PyBOP (1.21 g, 2.32 mmol) was added to the flask containing the carboxylate and after 1 min, freshly deblocked S5 was added dropwise over 2 min. The reaction mixture was stirred from 0 °C to room temperature over 3 h. The solvent was removed in vacuo and the concentrate was dissolved in 150 mL of EtOAc, washed with sat. aq. NH 4 Cl (2 x 75 mL), sat. aq. NaHCO 3 (2 x 75 mL) and brine (1 x 75 mL). The organic layer was concentrated in vacuo and purified by silica gel chromatography using a gradient of 60: 40 EtOAc: Hex to 80: 20 EtOAc: Hex over 3 L to obtain the product as a white foam (2.38 g, 62%) . 
S8
N-tert-Butyloxycarbonyl-L-[p-(tert-butyldimethylsilyl)phenyl]glycyl-L-arginyl(Pbf)-D-[p-(tert-
butyldimethylsilyl)phenyl]glycyl-L-seryl-S-pantetheine dimethyl ketal (S8).
To a 100 mL round- 
L-[p-(hydroxy)phenyl]glycyl-L-arginyl-D-[p-(hydroxy)phenyl]glycyl-dehydroalanyl-S-3'-
dephospho-coenzyme A (6). The title compound was obtained through established procedures utilizing the previously reported E. coli coenzyme A biosynthetic enzymes PanK and Ppat. 2, 3 To a 2.0 mL centrifugal tube was added freshly purified compound S9 (6 mg, 7.31 µmol) in 500 µL of buffer consisting of 50 mM Tris, 25 mM NaCl, 5 mM ATP and 1 mM MgCl 2 , pH 7.5. To this mixture was added 1.5 eq of PanK enzyme. After 45 min, 1.5 eq of Ppat was added and the reaction was allowed to proceed for 1 h. Enzymes were removed with a 10 kMWCO Amicon Ultra centrifugal filter. The flow-through was purified by HPLC using Prep Method A, the product was collected over multiple injections, frozen on dry ice and lyophilized to dryness to afford a white TFA salt (1 mg, 11%). 
